A Review of the Emergence and Expansion of Cardiovascular Genetic Counseling
Purpose of Review
The genetic counseling profession is growing rapidly, as is its presence in cardiology. In this review, we will survey recent innovations and research in cardiovascular genetic counseling, as well as findings from the broader genetic counseling field that are relevant to cardiovascular genetic counseling.
Research into the structure of services finds that genetic counselors are increasingly being embedded within cardiology departments and that cardiologists value their expertise and contributions. Findings from other genetic counseling subspecialties and from clinical psychology suggest this trend toward moving genetic counselors into the cardiology clinic will increase access, timeliness, and uptake of genetics services. Studies on the selection and interpretation of genetic tests in cardiology have shown that there is a need for specialized expertise in these areas. This has led clinical genetic counselors, in collaboration with their physician colleagues, to take a more active role in assessing whether genetic variants contribute to disease. Evidence on the psychological and behavioral impact of cardiovascular genetic counseling is beginning to emerge with several non-randomized and one randomized study showing benefit. As investigators, genetic counselors are leading studies that generate practice-shaping insights into inherited cardiovascular disease, including the genetic underpinnings of disease, natural history, prognosis, psychological impact, and genetic test interpretation.
Genetic counseling is in its early days as an academic and scientific discipline, yet there are, nonetheless, several notable recent findings that are shaping the field.
KeywordsGenetic counseling Cardiac genetics Interdisciplinary care Genetic testing Service delivery Cardiovascular genetic counseling
Compliance with Ethical Standards
Conflict of Interest
Tia Moscarello declares she has no conflicts of interest. Colleen Caleshu declares intellectual property and receives royalties for genome interpretation technology; she is a stockholder of Personalis, an advisor to Phosphorus and Gene Matters, and a consultant for Clear Genetics and Myokardia.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 3.National Society of Genetic Counselors Professional Status Survey Subcommittee. National Society of Genetic Counselors Professional Status Survey 2018: Work Environment Report. 2018.Google Scholar
- 4.Accreditation Council of Genetic Counseling. Standards of accreditation for graduate programs in Genetic Counseling [Internet]. 2013 Feb. Available: https://www.gceducation.org/standards-of-accreditation/
- 5.Genetic Counselors : Occupational Outlook Handbook: : U.S. Bureau of Labor Statistics [Internet]. 12 Apr 2019 [cited 10 Jul 2019]. Available: https://www.bls.gov/ooh/healthcare/genetic-counselors.htm
- 6.Professional Status Survey Subcommittee. National Society of Genetic Counselors Professional Status Survey Executive Summary. 2018.Google Scholar
- 7.National Society of Genetic Counselors Professional Issues Committee. National Society of Genetic Counselors Professional Status Survey 2006. 2006.Google Scholar
- 10.Towbin JA, McKenna WJ, Abrams DJ, Ackerman MJ, Calkins H, Darrieux FCC, et al. 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy. Heart Rhythm. 2019. https://doi.org/10.1016/j.hrthm.2019.05.007.PubMedCrossRefPubMedCentralGoogle Scholar
- 12.Priori SG, Wilde AA, Horie M, Cho Y, Behr ER, Berul C, et al. HRS/EHRA/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013. Heart Rhythm. 2013;10:1932–63.PubMedCrossRefPubMedCentralGoogle Scholar
- 14.Hiratzka LF, Bakris GL, Beckman JA, Bersin RM, Carr VF, Casey DE Jr, et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thora. Catheter Cardiovasc Interv. 2010;76:E43–86.PubMedCrossRefGoogle Scholar
- 15.Ackerman MJ, Priori SG, Willems S, Berul C, Brugada R, Calkins H, et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm. 2011;8:1308–39.PubMedCrossRefPubMedCentralGoogle Scholar
- 16.ABGC - American Board of Genetic Counseling, Inc. | ABGC [Internet]. [cited 23 Jul 2019]. Available: https://www.abgc.net/
- 17.Professional Status Survey Subcommittee. National Society of Genetic Counselors Professional Status Survey 2008 [Internet].Google Scholar
- 18.Professional Status Survey Subcommittee. National Society of Genetic Counselors Professional Status Survey 2010: Work Environment Report [Internet].Google Scholar
- 19.Professional Status Survey Subcommittee. National Society of Genetic Counselors Professional Status Survey 2012: Work Environment Report [Internet].Google Scholar
- 20.Professional Status Survey Subcommittee. National Society of Genetic Counselors Professional Status Survey 2016: Work Environment Report [Internet].Google Scholar
- 21.Professional Status Survey Subcommittee. National Society of Genetic Counselors Professional Status Survey: 2014 Work Environment Report. 2014.Google Scholar
- 23.• Athens BA, Caldwell SL, Umstead KL, Connors PD, Brenna E, Biesecker BB. A systematic review of randomized controlled trials to assess outcomes of genetic counseling. J Genet Couns. 2017;26:902–33 Athens et al. describe the first meta-analysis of randomized control trials in genetic counseling, identifying 58 studies that fit criteria. Psychological well-being was assessed in 40 out of 52 (69%) publications; specifically, anxiety, depressive symptoms, intrusive thoughts, quality of life, and disease-specific worry were assessed. Thirty one (59%) publications assessed service delivery models (i.e., telephone versus in-person genetic counseling). Most (76%) trials were conducted in cancer genetics, and none in cardiovascular genetics.PubMedCrossRefPubMedCentralGoogle Scholar
- 24.Spoonamore K, Orland K, Caleshu C. Who are the cardiologists early to adopt integration of genetic counselors into clinical practice? [Internet]. J. Genet. Couns. 2016. https://doi.org/10.1007/s10897-016-0027-x.
- 29.• Helm BM, Freeze SL, Spoonamore KG, Ware SM, Ayers MD, Kean AC. The genetic counselor in the pediatric arrhythmia clinic: review and assessment of services. J Genet Couns. 2018;27:558–64 Helm et al. describe the establishment of a multidisciplinary pediatric arrhythmia clinic. After screening the pediatric electrophysiologists’ clinic schedule, the team determined that 14.4% were appropriate for genetic counseling, most often due to a personal history of disease (75% of patients). The most common indications were long QT syndrome or other possible cardiac channelopathy.PubMedCrossRefPubMedCentralGoogle Scholar
- 30.• Reuter C, Grove ME, Orland K, Spoonamore K, Caleshu C. Clinical cardiovascular genetic counselors take a leading role in team-based variant classification. J Genet Couns. 2018;27:751–60 Reuter et al. surveyed cardiovascular genetic counselors, almost all of whom work with a cardiologist who specializes in inherited cardiovascular disease. Nearly all (95.7%) of genetic counselors surveyed gather additional data on the variants identified via genetic testing, and most (81.4%) assess pathogenicity. A role historically thought to be the purview of laboratories has been taken on by clinicians, and qualitative responses suggest this practice started due to inconsistent interpretations between laboratories, and mismanagement of families based on genetic test results.PubMedCrossRefPubMedCentralGoogle Scholar
- 48.Furqan A, Arscott P, Girolami F, Cirino AL, Michels M, Day SM, et al. Care in specialized centers and data sharing increase agreement in hypertrophic cardiomyopathy genetic test interpretation. Circ Cardiovasc Genet. 2017;10. https://doi.org/10.1161/CIRCGENETICS.116.001700.
- 52.Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–24.PubMedPubMedCentralCrossRefGoogle Scholar
- 53.• Kelly MA, Caleshu C, Morales A, Buchan J, Wolf Z, Harrison SM, et al. Adaptation and validation of the ACMG/AMP variant classification framework for MYH7-associated inherited cardiomyopathies: recommendations by ClinGen’s Inherited Cardiomyopathy Expert Panel. Genet Med. 2018;20:351–9 The ClinGen Inherited Cardiomyopathy Expert Panel created gene-specific guidelines for the interpretation of MYH7 variants. These guidelines stress the importance of rigorous review of case data and segregation data and that disease-causing MYH7 must be exceedingly rare in general population databases. Less emphasis is placed on functional and in silico data, as assays for MYH7 do not recapitulate the native cellular environment.PubMedPubMedCentralCrossRefGoogle Scholar
- 57.Tandy-Connor S, Guiltinan J, Krempely K, LaDuca H, Reineke P, Gutierrez S, et al. False-positive results released by direct-to-consumer genetic tests highlight the importance of clinical confirmation testing for appropriate patient care. Genet Med. 2018;20:1515–21.PubMedPubMedCentralCrossRefGoogle Scholar
- 65.Murray B. Genetic counseling is associated with increased empowerment and decreased fear in patients with arrhythmogenic cardiomyopathy (ACM). Heart Rhythm Society 2019; San Francisco.Google Scholar
- 66.• S-AN B, Jouni H, Marroush TS, Kullo IJ. Effect of disclosing genetic risk for coronary heart disease on information seeking and sharing: the MI-GENES study (Myocardial Infarction Genes). Circ Cardiovasc Genet. 2017;10. https://doi.org/10.1161/CIRCGENETICS.116.001613 Two hundred and three patients who learned about their personalized risk for coronary artery disease via a polygenic risk score and delivered by a genetic counselor were more likely to act on the information than patients who did not. Patients who received a risk score were more likely to seek more information about coronary artery disease and discuss their risk with their primary care physician and family members.
- 69.Nordestgaard BG, Chapman MJ, Humphries SE, Ginsberg HN, Masana L, Descamps OS, et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J. 2013;34:3478–90.PubMedPubMedCentralCrossRefGoogle Scholar
- 73.Heather Zierhut And. The impact of New CMS rules for telehealth on cancer genetic counseling. Am J Manag Care. 2018; Available: https://www.ajmc.com/journals/evidence-based-oncology/2018/june-2018/the-impact-of-new-cms-rules-for-telehealth-on-cancer-genetic-counseling
- 80.Wang W, Orgeron G, Tichnell C, Murray B, Crosson J, Monfredi O, et al. Impact of exercise restriction on arrhythmic risk among patients with arrhythmogenic right ventricular cardiomyopathy. J Am Heart Assoc. 2018;7. https://doi.org/10.1161/JAHA.118.008843.
- 81.Judge DP, Calkins H, James CA. Exercise has a disproportionate role in the pathogenesis of arrhythmogenic right ventricular dysplasia/cardiomyopathy in patients without desmosomal mutations. J Am Heart Assoc. 2014; Available: https://www.ahajournals.org/doi/abs/10.1161/JAHA.114.001471
- 82.• James CA, Bhonsale A, Tichnell C, Murray B, Russell SD, Tandri H, et al. Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy--associated desmosomal mutation carriers. J Am Coll Cardiol. 2013;62:1290–7 This is the first of several studies led by a genetic counselor which suggests that patients who were endurance athletes prior to a diagnosis of arrhythmogenic right ventricular cardiomyopathy are more likely to meet ARVC Task Force Criteria and experience a more severe course with a marked incidence of ventricular tachycardia and/or fibrillation. Sixty-four percent of patients were endurance athletes prior to diagnosis.PubMedCrossRefPubMedCentralGoogle Scholar
- 86.Miller EM, Hinton RB, Czosek R, Lorts A, Parrott A, Shikany AR, et al. Genetic testing in pediatric left ventricular noncompaction. Circ Cardiovasc Genet. 2017;10. https://doi.org/10.1161/CIRCGENETICS.117.001735.
- 87.Burns C, Bagnall RD, Lam L, Semsarian C, Ingles J. Multiple gene variants in hypertrophic cardiomyopathy in the era of next-generation sequencing. Circ Cardiovasc Genet. 2017;10. https://doi.org/10.1161/CIRCGENETICS.116.001666.